181 related articles for article (PubMed ID: 30701356)
1. Genetic and epigenetic analysis of the BAX and BCL2 in the placenta of pregnant women complicated by preeclampsia.
Mohammadpour-Gharehbagh A; Jahantigh D; Eskandari M; Sadegh MH; Nematollahi MH; Rezaei M; Rasouli A; Eskandari F; Heydarabad MZ; Teimoori B; Salimi S
Apoptosis; 2019 Apr; 24(3-4):301-311. PubMed ID: 30701356
[TBL] [Abstract][Full Text] [Related]
2. Analysis of polymorphisms, promoter methylation, and mRNA expression profile of maternal and placental P53 and P21 genes in preeclamptic and normotensive pregnant women.
Harati-Sadegh M; Kohan L; Teimoori B; Mehrabani M; Salimi S
J Biomed Sci; 2019 Nov; 26(1):92. PubMed ID: 31703578
[TBL] [Abstract][Full Text] [Related]
3. The association of the placental MTHFR 3'-UTR polymorphisms, promoter methylation, and MTHFR expression with preeclampsia.
Mohammadpour-Gharehbagh A; Teimoori B; Narooei-Nejad M; Mehrabani M; Saravani R; Salimi S
J Cell Biochem; 2018 Feb; 119(2):1346-1354. PubMed ID: 28722783
[TBL] [Abstract][Full Text] [Related]
4. The effects of placental long noncoding RNA H19 polymorphisms and promoter methylation on H19 expression in association with preeclampsia susceptibility.
Harati-Sadegh M; Kohan L; Teimoori B; Mehrabani M; Salimi S
IUBMB Life; 2020 Mar; 72(3):413-425. PubMed ID: 31769935
[TBL] [Abstract][Full Text] [Related]
5. Influence of BCL2-938C>A and BAX-248G>A promoter polymorphisms in the development of AML: case-control study from South India.
Cingeetham A; Vuree S; Dunna NR; Gorre M; Nanchari SR; Edathara PM; Meka P; Annamaneni S; Digumarthi R; Sinha S; Satti V
Tumour Biol; 2015 Sep; 36(10):7967-76. PubMed ID: 25957891
[TBL] [Abstract][Full Text] [Related]
6. BAX and BCL2 Gene Polymorphisms in Rhegmatogenous Retinal Detachment.
Moschos MM; Chatziralli I; Brouzas D; Gazouli M
Ophthalmic Res; 2017; 58(4):227-230. PubMed ID: 28877516
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the Polymorphisms and Expression Levels of the BCL2, BAX and c-MYC Genes in Patients with Ovarian Cancer.
Olbromski PJ; Bogacz A; Bukowska M; Kamiński A; Moszyński R; Pawlik P; Szeliga A; Kotrych K; Czerny B
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003498
[TBL] [Abstract][Full Text] [Related]
8. Association of the placental VEGF promoter polymorphisms and VEGF mRNA expression with preeclampsia.
Keshavarzi F; Shahrakipoor M; Teimoori B; Yaghmaei M; Narooei-Nejad M; Rasooli A; Salimi S
Clin Exp Hypertens; 2019; 41(3):274-279. PubMed ID: 29771604
[TBL] [Abstract][Full Text] [Related]
9. Polymorphism in apoptotic BAX (-248G>A) gene but not in anti-apoptotic BCL2 (-938C>A) gene and its protein and mRNA expression are associated with cervical intraepithelial neoplasia.
Fernandes AT; Rocha NP; Vendrame E; Russomano F; Grinsztejn BJ; Friedman RK; Pinto AC; Klumb EM; Avvad E; Macedo J; Martínez-Maza O; Bonecini-Almeida Mda G
Apoptosis; 2015 Oct; 20(10):1347-57. PubMed ID: 26272263
[TBL] [Abstract][Full Text] [Related]
10. The role of TNF-α and TLR4 polymorphisms in the placenta of pregnant women complicated by preeclampsia and in silico analysis.
Mohammadpour-Gharehbagh A; Jahantigh D; Eskandari M; Eskandari F; Rezaei M; Zeynali-Moghaddam S; Teimoori B; Salimi S
Int J Biol Macromol; 2019 Aug; 134():1205-1215. PubMed ID: 31071395
[TBL] [Abstract][Full Text] [Related]
11. The association of the placental Hypoxia-inducible factor1-α polymorphisms and HIF1-α mRNA expression with preeclampsia.
Harati-Sadegh M; Kohan L; Teimoori B; Mehrabani M; Salimi S
Placenta; 2018 Jul; 67():31-37. PubMed ID: 29941171
[TBL] [Abstract][Full Text] [Related]
12. Impact of HOTAIR variants on preeclampsia susceptibility based on blood and placenta and in silico analysis.
Mohammadpour-Gharehbagh A; Jahantigh D; Saravani M; Harati-Sadegh M; Maruie-Milan R; Teimoori B; Salimi S
IUBMB Life; 2019 Sep; 71(9):1367-1381. PubMed ID: 31188529
[TBL] [Abstract][Full Text] [Related]
13. Relationships between Dicer 1 polymorphism and expression levels in the etiopathogenesis of preeclampsia.
Eskandari F; Teimoori B; Rezaei M; Mohammadpour-Gharehbagh A; Narooei-Nejad M; Mehrabani M; Salimi S
J Cell Biochem; 2018 Jul; 119(7):5563-5570. PubMed ID: 29377251
[TBL] [Abstract][Full Text] [Related]
14. Single-nucleotide polymorphisms at the TP53-binding or responsive promoter regions of BAX and BCL2 genes and risk of squamous cell carcinoma of the head and neck.
Chen K; Hu Z; Wang LE; Sturgis EM; El-Naggar AK; Zhang W; Wei Q
Carcinogenesis; 2007 Sep; 28(9):2008-12. PubMed ID: 17693666
[TBL] [Abstract][Full Text] [Related]
15. Hypomethylation of tissue factor pathway inhibitor 2 in human placenta of preeclampsia.
Xiao X; Tao X; Wang Y; Zhu L; Ye Y; Liu H; Zhou Q; Li X; Xiong Y
Thromb Res; 2017 Apr; 152():7-13. PubMed ID: 28208084
[TBL] [Abstract][Full Text] [Related]
16. The role of FAS, FAS-L, BAX, and BCL-2 gene polymorphisms in determining susceptibility to unexplained recurrent pregnancy loss.
Michita RT; Zambra FMB; Fraga LR; Sanseverino MT; Schuler-Faccini L; Chies JAB; Vianna P
J Assist Reprod Genet; 2019 May; 36(5):995-1002. PubMed ID: 30937706
[TBL] [Abstract][Full Text] [Related]
17. Polymorphisms of BCL2 and BAX Genes Associate with Outcomes in Advanced Non-small cell lung cancer Patients treated with platinum-based Chemotherapy.
Peng Y; Wang L; Qing Y; Li C; Ren T; Li Q; Li M; Zhang S; Shan J; Wang G; Yang Z; Wang D
Sci Rep; 2015 Dec; 5():17766. PubMed ID: 26656462
[TBL] [Abstract][Full Text] [Related]
18. The placental vascular endothelial growth factor polymorphisms and preeclampsia/preeclampsia severity.
Keshavarzi F; Mohammadpour-Gharehbagh A; Shahrakipour M; Teimoori B; Yazdi A; Yaghmaei M; Naroeei-Nejad M; Salimi S
Clin Exp Hypertens; 2017; 39(7):606-611. PubMed ID: 28665739
[TBL] [Abstract][Full Text] [Related]
19. Investigating the Association of IL-17A and IL-17F with Susceptibility to Pre-eclampsia in Iranian Women.
Anvari F; Dabagh-Gorjani F; Soltani-Zangbar MS; Kamali-Sarvestani E; Malek-Hosseini Z; Gharesi-Fard B
Iran J Immunol; 2015 Jun; 12(2):117-28. PubMed ID: 26119194
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic mechanisms regulate placental c-myc and hTERT in normal and pathological pregnancies; c-myc as a novel fetal DNA epigenetic marker for pre-eclampsia.
Rahat B; Hamid A; Ahmad Najar R; Bagga R; Kaur J
Mol Hum Reprod; 2014 Oct; 20(10):1026-40. PubMed ID: 25024139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
